[go: up one dir, main page]

FR3002831B1 - FOOD PRODUCT READY TO BE CONSUMED FOR PATIENTS WITH METABOLIC DISEASE OF ONE OR MORE AMINO ACIDS - Google Patents

FOOD PRODUCT READY TO BE CONSUMED FOR PATIENTS WITH METABOLIC DISEASE OF ONE OR MORE AMINO ACIDS

Info

Publication number
FR3002831B1
FR3002831B1 FR1352145A FR1352145A FR3002831B1 FR 3002831 B1 FR3002831 B1 FR 3002831B1 FR 1352145 A FR1352145 A FR 1352145A FR 1352145 A FR1352145 A FR 1352145A FR 3002831 B1 FR3002831 B1 FR 3002831B1
Authority
FR
France
Prior art keywords
consumed
patients
amino acids
food product
metabolic disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1352145A
Other languages
French (fr)
Other versions
FR3002831A1 (en
Inventor
Amandine Ligneul
Ruyet Pascale Le
Rachel Zatti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lactalis Nutrition Sante SAS
Original Assignee
Lactalis Nutrition Sante SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lactalis Nutrition Sante SAS filed Critical Lactalis Nutrition Sante SAS
Priority to FR1352145A priority Critical patent/FR3002831B1/en
Publication of FR3002831A1 publication Critical patent/FR3002831A1/en
Application granted granted Critical
Publication of FR3002831B1 publication Critical patent/FR3002831B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L23/00—Soups; Sauces; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pediatric Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR1352145A 2013-03-11 2013-03-11 FOOD PRODUCT READY TO BE CONSUMED FOR PATIENTS WITH METABOLIC DISEASE OF ONE OR MORE AMINO ACIDS Active FR3002831B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1352145A FR3002831B1 (en) 2013-03-11 2013-03-11 FOOD PRODUCT READY TO BE CONSUMED FOR PATIENTS WITH METABOLIC DISEASE OF ONE OR MORE AMINO ACIDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1352145A FR3002831B1 (en) 2013-03-11 2013-03-11 FOOD PRODUCT READY TO BE CONSUMED FOR PATIENTS WITH METABOLIC DISEASE OF ONE OR MORE AMINO ACIDS

Publications (2)

Publication Number Publication Date
FR3002831A1 FR3002831A1 (en) 2014-09-12
FR3002831B1 true FR3002831B1 (en) 2015-07-17

Family

ID=48699048

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1352145A Active FR3002831B1 (en) 2013-03-11 2013-03-11 FOOD PRODUCT READY TO BE CONSUMED FOR PATIENTS WITH METABOLIC DISEASE OF ONE OR MORE AMINO ACIDS

Country Status (1)

Country Link
FR (1) FR3002831B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800006268A1 (en) * 2018-06-13 2019-12-13 NUTRITIONAL FORMULATION FOR THE MANAGEMENT OF THE DIET FOR PHENYLKETONURIA AND METHOD OF IMPLEMENTATION
WO2025088004A1 (en) 2023-10-27 2025-05-01 Société des Produits Nestlé S.A. Paediatric formulations for phenylketonuria and tyrosinaemia and specific free amino acid mixture

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0799577B1 (en) * 1994-10-14 2001-02-14 Morinaga Milk Industry Co., Ltd. Peptide mixture and products thereof
DE19534602C2 (en) * 1995-09-18 1999-09-09 Milupa Ag Use of threonine to treat phenylketonuria
DE69726738T2 (en) * 1996-08-30 2004-10-21 Nestle Sa NUTRITIONAL RECIPE FOR PHENYLKETONURIA PATIENTS
DE69904511T2 (en) * 1998-10-16 2003-05-28 Societe Des Produits Nestle S.A., Vevey PROTEIN MATERIAL WITH SLOW DEGREASING PROCESS AND THEIR USE
WO2008118850A2 (en) * 2007-03-23 2008-10-02 Cambrooke Foods, Llc Dietary compositions
BRPI1013089A2 (en) * 2009-06-12 2016-04-05 Wisconsin Alumni Res Found medicinal food and methods for preparing a medicinal food and for treating a metabolic disorder
WO2012050434A1 (en) * 2010-10-15 2012-04-19 N.V. Nutricia Dairy based smoothie for stimulating growth in children

Also Published As

Publication number Publication date
FR3002831A1 (en) 2014-09-12

Similar Documents

Publication Publication Date Title
EP2790736A4 (en) IN VIVO ADMINISTRATION OF OLIGONUCLEOTIDES
IL263843B (en) Antisense compounds containing an antisense oligonucleotide complementary to nucleic acid transcription and compositions containing them for the treatment of related metabolic diseases
EP2959019A4 (en) METHODS OF SEQUENCING NUCLEIC ACIDS IN MIXTURES AND ASSOCIATED COMPOSITIONS
LT2892436T (en) TREATMENT OF HEAD PAIN BY INJECTION OF A NEUROINHIBIC SUBSTANCE IN THE WING IN THE WOMAN
IL269511A (en) New therapeutic approaches to treat Parkinson's disease
PL2707015T5 (en) Lixisenatide as adjunct therapy to basal insulin in type 2 diabetes
EP2683382A4 (en) DOSAGE REGIMES FOR THE TREATMENT OF FABRY'S DISEASE
PL2717692T3 (en) TETRAHYDROCANNABINOL-11-OWE ACIDS FOR USE IN THE TREATMENT OF FIBERATAL DISEASES
EP2701737A4 (en) SYNTHETIC TOLEROGENOUS NANOSUPPORTS FOR THERAPY OF ALLERGY
BR112013032469A2 (en) composition, method of synthesizing fumaryl diquetopiperazine microparticles, method of delivering insulin to a patient in need thereof and diquetopiperazine microparticle
EP2707510A4 (en) INSULATION OF NUCLEIC ACIDS
EP2797620A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF INEFFECTIVE ERYTHROPOYSIS
EP2981551A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF PUMP DISEASE
EP2753701A4 (en) ACYL-ACP SYNTHASE OF SKIN ESTER
HUE065346T2 (en) Treatment of metabolic disorders in cats
IL221744A (en) Use of a combination of compounds to prepare a drug to treat Parkinson's disease
EP2717698A4 (en) ANTIHISTAMINES COMBINED WITH FOOD SUPPLEMENTS TO IMPROVE HEALTH
ZA201400559B (en) Methods for the production of a cosmetic composition from hatching fluid of salmonidae eggs and uses thereof for improving the cosmetic appearance of skin
ITTO20110627A1 (en) PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS TO TREAT DIABETES AND METABOLIC DISORDERS
ZA201402318B (en) Use of omega fatty acids for treating disease
PT2683372T (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF HYPERURICEMIA AND METABOLIC DISORDERS ASSOCIATED WITH HYPERURICEMIA
FR2993563B1 (en) THIOPHENE DERIVATIVES USEFUL IN THE TREATMENT OF DIABETES
EP2704723A4 (en) TREATMENT OF A POLYKYSTIC DISEASE
FR2973312B1 (en) END TIP FOR TUMBLING BRUSH
PT2895006T (en) Use of protein hydrolysates and nucleotides for enhancing palatability of fish feed

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13